individual immunizing agents
recommended immunizations by age group
for healthy children and adolescents
rotavirus vaccine
Rotarix > 2 dose series at 2 months and 4 months
RotaTeq > 3 dose series at 2, 3, and 6 months
do not start the series after 15 weeks; max age for final dose is 8 months
Diphtheria, tetanus, and pertussis
5 dose series of DTaP at ages 2, 4, 6, and 15-18 months and 4-6 years
DT if child allergic to pertussis
Pneumococcal
four dose series for healthy young children at 2, 4, 6, and 12 through 15 months
single dose if 6-18 years old and never vaccinated
chickenpox vaccine
two dose series with first dose at 12-15 months and second dose at 4-6 years
2 doses required for immunity
Haemophilus influenzae type B conjugate vaccine
six weeks old for 3 dose series or 2 dose series
booster at age 12-15 to complete a full Hib series
MMR
two dose series with the first dose at ages 12-15 months and second dose at 4-6 years
Hep A
two dose series with first dose at 1-2 years and second dose at least 6 months after
Hep B monovalent vaccine should be given to all newbrons within 24 hours of birth, second dose at age 1 to 2 months and third dose at least 8 weeks after second dose and 16 weeks after first dose
HPV vaccine (Gardasil 9)
for all adolescents 11 or 12 years of age or up to age 26
most effective before s*xual activity
Meningococcal vaccine
administration at 11 or 12 years of age
booster at 16
two serogroup B meningococcal (MenB) vaccines are recommended in those between age 16 and 23 years of age for short term protection against meningitis > preference of 16-18
COVID-19
for all children older than 5 years in 2-dose series of Pfizer
children 12 years and older should receive a booster at least 2 months after initial series
annual flu vaccine
for adults
chickenpox vaccine
for nonpregnant adults who have never had the disease of vaccine
second dose for those who have only had a single dose
HPV
for females up to 26 years
males up to 21
males 22-26 who have s*x with other males